abstract |
The invention relates to a dosage form comprising a physiologically active substance (A); optionally one or more physiologically acceptable excipients (B); a synthetic or natural polymer (C); and optionally a natural, semi-synthetic or synthetic wax (D); wherein the dosage form has a breaking strength of at least 400 N and under physiological conditions releases the physiologically active substance (A) at least partially retarded. |